Adherence to treatment in systemic lupus erythematosus patients

Abstract : Adherence is defined as "the extent to which a person's behaviour coincides with medical or health advice." Poor adherence to therapeutic regimens is a common and expensive problem in patients with chronic diseases including systemic lupus erythematosus (SLE) and is associated with a higher risk of flares, morbidity, hospitalisations and poor renal outcome. Non-adherence to the treatment is multifactorial for most patients and varies according to unintentional or intentional patterns. The rates of non-adherence in SLE patients range from 3% to 76% depending on the assessment methods, which are all subject to limitations. Indeed, poor adherence to therapeutic regimens is difficult to evaluate. Two studies have shown that undetectable blood hydroxychloroquine (HCQ) concentration may be a simple, objective and reliable marker of non-adherence in SLE patients. The accurate diagnosis of non-adherence may prevent one from incorrectly interpreting disease manifestations as a lack of response. It may then avoid an unnecessary or even dangerous treatment escalation.
Document type :
Journal articles
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-01791229
Contributor : Apemac Ul <>
Submitted on : Monday, May 14, 2018 - 2:44:27 PM
Last modification on : Monday, August 12, 2019 - 3:58:05 PM

Identifiers

Collections

Citation

Nathalie Costedoat-Chalumeau, Jacques Pouchot, Gaëlle Guettrot-Imbert, Veronique Le Guern, Gaëlle Leroux, et al.. Adherence to treatment in systemic lupus erythematosus patients. Best Practice and Research: Clinical Rheumatology, Elsevier, 2013, 27 (3), pp.329 - 340. ⟨10.1016/j.berh.2013.07.001⟩. ⟨hal-01791229⟩

Share

Metrics

Record views

30